Related Experiment Videos
Insights
Acute cerebral revascularization for acute ischemic stroke showed promising results, with most patients experiencing symptom resolution within 10 hours post-surgery. This procedure appears safe and beneficial for select stroke patients, warranting further investigation.
Area of Science:
- Neurology
- Neurosurgery
- Vascular Surgery
Background:
- Acute cerebral ischemia presents a critical medical emergency requiring timely intervention.
- Traditional treatments like heparin showed limited efficacy in improving neurological function for acute stroke patients.
- Surgical intervention, specifically acute cerebral revascularization, was explored as a potential treatment option.
Observation:
- Fifteen patients with acute cerebral ischemia underwent acute cerebral revascularization between 1979 and 1983.
- Patients presented with varying degrees of neurological deficits, including crescendo transient ischemic attacks (TIAs), progressing dysfunction, and completed deficits.
- Surgical timing varied based on clinical presentation, ranging from within 4 hours of the last event to 12 hours after the deficit began.
Findings:
- Ten out of fifteen patients experienced clinical resolution within 10 hours after surgery.
- Five patients (33%) had residual deficits post-operation, with three mild and two severe.
- One patient developed an intracerebral hematoma, indicating a potential risk associated with the procedure.
Implications:
- Acute cerebral revascularization can be performed safely with limited risks in carefully selected patients with acute cerebral ischemia.
- The procedure offers potential benefits for improving outcomes in acute stroke patients.
- Further controlled, randomized studies are necessary to definitively establish the efficacy and safety of acute cerebral revascularization.
Abstract:
Fifteen patients evaluated for acute cerebral ischemia underwent acute cerebral revascularization between March, 1979, and May, 1983. Clinical presentation included crescendo transient ischemic attacks (TIA's) in eight cases, progressing neurological dysfunction in three cases, and completed nonfluctuating deficits in four cases. Nine patients received intravenous heparin but did not improve neurologically. The patients with crescendo TIA's were operated on within 4 hours of their last event; those with progressing deficits were operated on while the deficit was developing, and those with established deficits were operated on 4, 6, 9, and 12 hours, respectively, after the event began. The clinical picture for 10 patients had resolved within 10 hours after surgery. One patient with crescendo TIA's, two with progressing deficits, and two with established deficits had postoperative residual deficits, of which three were mild and two severe. One patient, who had a saphenous vein graft to the middle cerebral artery, developed an intracerebral hematoma. In this prospective noncontrolled nonrandomized study, acute cerebral revascularization was performed safely, had limited risks, and offered the potential to help some patients. Further controlled randomized studies are indicated.